Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...
-
HAMPTON, Va., March 23, 2016 (GLOBE NEWSWIRE) -- As noted by the National Cancer Institute, "cancer health disparities" continue to exist among certain population groups and regions. These vulnerable...
-
PHILADELPHIA, March 10, 2016 (GLOBE NEWSWIRE) -- With new studies recently uncovering a connection between certain types of carbohydrates and lung cancer, Diet Doc has placed added emphasis on...
-
HAMPTON, Va., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Patient Advocate Foundation (PAF), a national nonprofit dedicated to helping patients with serious illness access healthcare, has been awarded a...
-
CAPE TOWN, GLENVIEW, LAUSANNE, MONTEVIDEO, NEW YORK, PARIS, TOKYO, Feb. 1, 2016 (GLOBE NEWSWIRE) -- In recognition of World Cancer Day on February 4, American College of Chest Physicians, alongside...
-
TUSTIN, Calif., Jan. 20, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
-
TUSTIN, Calif., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
-
TUSTIN, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
-
AURORA, COLO., Oct. 1, 2015 (GLOBE NEWSWIRE) -- UCHealth's University of Colorado Hospital (UCH), a national leader in pulmonology, cancer and upper airway disorders, opens its new multidisciplinary...
-
TUSTIN, Calif., Sept. 08, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...